Synapse - Jae Park

Search Within

Jae Hong Park

Results (378)

Impact of allogeneic hematopoietic cell transplantation (HCT) as consolidation following CD19 chimeric antigen receptor (CAR) T cell therapy for treatment of relapsed acute lymphoblastic leukemia (ALL)

Meeting Abstract

Park, J. H.; Nikiforow, S.; Kim, S.; Hu, Z. H.; Moskop, A.; Ahmed, S.; Abid, M. B.; Badar, T.; Bredeson, C.; Brown, V.; more...
Blood (2021)

Fulltext@MSK | Save

First line chemo-free therapy with the BRAF inhibitor vemurafenib combined with obinutuzumab is effective in patients with HCL

Meeting Abstract

Park, J. H.; Winer, E. S.; Huntington, S. F.; von Keudell, G.; Vemuri, S.; Shukla, M.; Kinoshita, J. C.; Falco, V.; Gore, S. D.; Stone, R. M.; more...
Blood (2021)

Fulltext@MSK | Save

Maximal tolerated dose determined for venetoclax in combination with liposomal vincristine in patients with relapsed or refractory ph- negative T-cell or B-cell acute lymphoblastic leukemia: Results of phase 1 portion of ECOG-ACRIN EA9152

Meeting Abstract

Palmisiano, N.; Lee, J. W.; Claxton, D. F.; Paietta, E.; Alkhateeb, H. B.; Park, J. H.; Podoltsev, N.; Atallah, E. L.; Schaar, D. G.; Dinner, S.; more...
Blood (2021)

Fulltext@MSK | Save

Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma

Meeting Abstract

Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
Blood (2021)

Fulltext@MSK | Save

Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy

Meeting Abstract

Hubbeling, H.; Silverman, E. A.; Wijetunga, N. A.; Palomba, M. L.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
Blood (2021)

Fulltext@MSK | Save

Safety and efficacy of FT596, a first-in-class, multi-antigen targeted, off-the-shelf, iPSC-derived CD19 car NK cell therapy in relapsed/refractory B-cell lymphoma

Meeting Abstract

Bachanova, V.; Ghobadi, A.; Patel, K.; Park, J. H.; Flinn, I. W.; Shah, P.; Wong, C.; Bickers, C.; Szabo, P.; Wong, L.; more...
Blood (2021)

Fulltext@MSK | Save

A phase 2 study of dasatinib, prednisone, and blinatumomab for older patients with philadelphia-chromosome (Ph) positive or Ph-like acute lymphoblastic leukemia (ALL) (with dasatinib sensitive fusions/ mutations)

Meeting Abstract

Advani, A.; Moseley, A.; O'Dwyer, K.; Wood, B.; Park, J. H.; Wieduwilt, M.; Jeyakumar, D.; Yaghmour, G.; Atallah, E. L.; Gerds, A. T.; more...
Blood (2021)

Fulltext@MSK | Save

Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection

Journal Article

Peraro, L.; Bourne, C. M.; Dacek, M. M.; Akalin, E.; Park, J. H.; Smith, E. L.; Scheinberg, D. A.
Molecular Therapy (2021)

Fulltext@MSK | Save

Bridging chemotherapy prior to CD19-specific CAR T-cell therapy in children/young adults with relapsed/refractory acute lymphoblastic leukemia

Meeting Abstract

Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Boelens, J. J.; Forlenza, C.; Kernan, N.; Shukla, N.; Steinherz, P.; Sulis, M. L.; more...
Pediatric Blood and Cancer (2021)

Fulltext@MSK | Save

Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia

Research Letter

Perica, K.; Flynn, J.; Curran, K. J.; Rivere, I.; Wang, X.; Senechal, B.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; more...
Leukemia (2021)

Fulltext@MSK | Save